Lara-Marquez ML - Search Results

1

Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells.

Lara-Marquez ML, Mehta V, Michalsky MP, Fleming JB, Besner GE. Lara-Marquez ML, et al. Nitric Oxide. 2002 Mar;6(2):142-52. doi: 10.1006/niox.2001.0393. Nitric Oxide. 2002. PMID: 11890738

2

Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury.

Xia G, Lara-Marquez M, Luquette MH, Glenn S, Haque A, Besner GE. Xia G, et al. Antioxid Redox Signal. 2001 Oct;3(5):919-30. doi: 10.1089/15230860152665073. Antioxid Redox Signal. 2001. PMID: 11761337

3

Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk.

Michalsky MP, Lara-Marquez M, Chun L, Besner GE. Michalsky MP, et al. J Pediatr Surg. 2002 Jan;37(1):1-6. doi: 10.1053/jpsu.2002.29415. J Pediatr Surg. 2002. PMID: 11781977

4

Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.

Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B. Lara-Marquez M, et al. J Immunol. 2001 Feb 15;166(4):2522-30. doi: 10.4049/jimmunol.166.4.2522. J Immunol. 2001. PMID: 11160313

5

Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes.

Lara-Marquez ML, O'Dorisio MS, Karacay B. Lara-Marquez ML, et al. Ann N Y Acad Sci. 2000;921:45-54. doi: 10.1111/j.1749-6632.2000.tb06950.x. Ann N Y Acad Sci. 2000. PMID: 11193874

6

A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.

Summers MA, O'Dorisio MS, Cox MO, Lara-Marquez M, Goetzl EJ. Summers MA, et al. J Pharmacol Exp Ther. 2003 Aug;306(2):638-45. doi: 10.1124/jpet.103.050583. Epub 2003 May 15. J Pharmacol Exp Ther. 2003. PMID: 12750439

7

Defect in Th1-like cells of nonresponders to hepatitis B vaccine.

Chedid MG, Deulofeut H, Yunis DE, Lara-Marquez ML, Salazar M, Deulofeut R, Awdeh Z, Alper CA, Yunis EJ. Chedid MG, et al. Among authors: lara marquez ml. Hum Immunol. 1997 Nov;58(1):42-51. doi: 10.1016/s0198-8859(97)00209-7. Hum Immunol. 1997. PMID: 9438208

8

Atopic asthma: differential activation phenotypes among memory T helper cells.

Lara-Marquez ML, Moan MJ, Cartwright S, Listman J, Israel E, Perkins DL, Christiani DC, Finn PW. Lara-Marquez ML, et al. Clin Exp Allergy. 2001 Aug;31(8):1232-41. doi: 10.1046/j.1365-2222.2001.01146.x. Clin Exp Allergy. 2001. PMID: 11529893

9

Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population.

Lara-Marquez ML, Yunis JJ, Layrisse Z, Ortega F, Carvallo-Gil E, Montagnani S, Makhatadze NJ, Pocino M, Granja C, Yunis E. Lara-Marquez ML, et al. Clin Exp Allergy. 1999 Jan;29(1):60-71. doi: 10.1046/j.1365-2222.1999.00461.x. Clin Exp Allergy. 1999. PMID: 10051703

10

Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma.

Lara-Marquez ML, Deykin A, Krinzman S, Listman J, Israel E, He H, Christiani DC, Perkins DL, Finn PW. Lara-Marquez ML, et al. J Allergy Clin Immunol. 1998 May;101(5):699-708. doi: 10.1016/s0091-6749(98)70180-0. J Allergy Clin Immunol. 1998. PMID: 9600509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters